Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) Stock Competitors & Peer Comparison
See XLABW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Information Technology Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for XLABW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| XLABW | $0.20 | +100.90% | 5.7M | 0.98 | $0.20 | N/A |
| IBM | $232.14 | -0.85% | 218.7B | 19.54 | $11.88 | +2.91% |
| ACN | $229.68 | +2.12% | 140.6B | 16.77 | $13.70 | +2.92% |
| INFY | $12.24 | +0.91% | 49.7B | 14.76 | $0.83 | +4.31% |
| FI | $63.80 | +0.16% | 34.3B | 9.86 | $6.47 | N/A |
| CTSH | $66.03 | +0.40% | 29.7B | 11.98 | $5.51 | +1.99% |
| FISV | $47.55 | +0.72% | 25.3B | 7.35 | $6.47 | N/A |
| BR | $175.11 | +0.57% | 19.8B | 18.17 | $9.64 | +2.31% |
| WIT | $1.95 | +4.28% | 19.3B | 14.43 | $0.14 | +4.46% |
| CDW | $150.48 | -2.49% | 18.8B | 14.37 | $10.47 | +1.68% |
Stock Comparison
International Business Machines Corporation (NYSE: IBM)
XLABW vs IBM Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, IBM has a market cap of 218.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while IBM trades at $232.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas IBM's P/E ratio is 19.54. In terms of profitability, XLABW's ROE is N/A, compared to IBM's ROE of +0.34%. Regarding short-term risk, XLABW is more volatile compared to IBM. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check IBM's competition here
Accenture plc (NYSE: ACN)
XLABW vs ACN Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, ACN has a market cap of 140.6B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while ACN trades at $229.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas ACN's P/E ratio is 16.77. In terms of profitability, XLABW's ROE is N/A, compared to ACN's ROE of +0.27%. Regarding short-term risk, XLABW is more volatile compared to ACN. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check ACN's competition here
Infosys Limited (NYSE: INFY)
XLABW vs INFY Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, INFY has a market cap of 49.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while INFY trades at $12.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas INFY's P/E ratio is 14.76. In terms of profitability, XLABW's ROE is N/A, compared to INFY's ROE of +0.33%. Regarding short-term risk, XLABW is more volatile compared to INFY. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check INFY's competition here
Fiserv, Inc. (NYSE: FI)
XLABW vs FI Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, FI has a market cap of 34.3B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while FI trades at $63.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas FI's P/E ratio is 9.86. In terms of profitability, XLABW's ROE is N/A, compared to FI's ROE of +0.11%. Regarding short-term risk, XLABW is more volatile compared to FI. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check FI's competition here
Cognizant Technology Solutions Corporation (NASDAQ: CTSH)
XLABW vs CTSH Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CTSH has a market cap of 29.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CTSH trades at $66.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CTSH's P/E ratio is 11.98. In terms of profitability, XLABW's ROE is N/A, compared to CTSH's ROE of +0.15%. Regarding short-term risk, XLABW is more volatile compared to CTSH. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CTSH's competition here
Fiserv, Inc. (NASDAQ: FISV)
XLABW vs FISV Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, FISV has a market cap of 25.3B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while FISV trades at $47.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas FISV's P/E ratio is 7.35. In terms of profitability, XLABW's ROE is N/A, compared to FISV's ROE of +0.11%. Regarding short-term risk, XLABW is more volatile compared to FISV. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check FISV's competition here
Broadridge Financial Solutions, Inc. (NYSE: BR)
XLABW vs BR Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, BR has a market cap of 19.8B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while BR trades at $175.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas BR's P/E ratio is 18.17. In terms of profitability, XLABW's ROE is N/A, compared to BR's ROE of +0.40%. Regarding short-term risk, XLABW is more volatile compared to BR. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check BR's competition here
Wipro Limited (NYSE: WIT)
XLABW vs WIT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, WIT has a market cap of 19.3B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while WIT trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas WIT's P/E ratio is 14.43. In terms of profitability, XLABW's ROE is N/A, compared to WIT's ROE of +0.16%. Regarding short-term risk, XLABW is more volatile compared to WIT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check WIT's competition here
CDW Corporation (NASDAQ: CDW)
XLABW vs CDW Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CDW has a market cap of 18.8B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CDW trades at $150.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CDW's P/E ratio is 14.37. In terms of profitability, XLABW's ROE is N/A, compared to CDW's ROE of +0.43%. Regarding short-term risk, XLABW is more volatile compared to CDW. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CDW's competition here
Fidelity National Information Services, Inc. (NYSE: FIS)
XLABW vs FIS Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, FIS has a market cap of 18.6B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while FIS trades at $36.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas FIS's P/E ratio is 5.97. In terms of profitability, XLABW's ROE is N/A, compared to FIS's ROE of +0.23%. Regarding short-term risk, XLABW is more volatile compared to FIS. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check FIS's competition here
Leidos Holdings, Inc. (NYSE: LDOS)
XLABW vs LDOS Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, LDOS has a market cap of 15.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while LDOS trades at $124.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas LDOS's P/E ratio is 10.24. In terms of profitability, XLABW's ROE is N/A, compared to LDOS's ROE of +0.28%. Regarding short-term risk, XLABW is more volatile compared to LDOS. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check LDOS's competition here
CGI Inc. (NYSE: GIB)
XLABW vs GIB Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, GIB has a market cap of 13.8B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while GIB trades at $75.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas GIB's P/E ratio is 12.08. In terms of profitability, XLABW's ROE is N/A, compared to GIB's ROE of +0.17%. Regarding short-term risk, XLABW is more volatile compared to GIB. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check GIB's competition here
CACI International Inc (NYSE: CACI)
XLABW vs CACI Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CACI has a market cap of 13.6B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CACI trades at $614.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CACI's P/E ratio is 20.58. In terms of profitability, XLABW's ROE is N/A, compared to CACI's ROE of +0.13%. Regarding short-term risk, XLABW is more volatile compared to CACI. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CACI's competition here
Gartner, Inc. (NYSE: IT)
XLABW vs IT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, IT has a market cap of 13B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while IT trades at $205.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas IT's P/E ratio is 14.27. In terms of profitability, XLABW's ROE is N/A, compared to IT's ROE of +4.01%. Regarding short-term risk, XLABW is more volatile compared to IT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check IT's competition here
Wise plc (NASDAQ: WSE)
XLABW vs WSE Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, WSE has a market cap of 11B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while WSE trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas WSE's P/E ratio is 22.88. In terms of profitability, XLABW's ROE is N/A, compared to WSE's ROE of +0.26%. Regarding short-term risk, XLABW is more volatile compared to WSE. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check WSE's competition here
Jack Henry & Associates, Inc. (NASDAQ: JKHY)
XLABW vs JKHY Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, JKHY has a market cap of 10.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while JKHY trades at $153.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas JKHY's P/E ratio is 21.42. In terms of profitability, XLABW's ROE is N/A, compared to JKHY's ROE of +0.23%. Regarding short-term risk, XLABW is more volatile compared to JKHY. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check JKHY's competition here
Genpact Limited (NYSE: G)
XLABW vs G Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, G has a market cap of 6.3B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while G trades at $37.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas G's P/E ratio is 9.80. In terms of profitability, XLABW's ROE is N/A, compared to G's ROE of +0.23%. Regarding short-term risk, XLABW is more volatile compared to G. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check G's competition here
EPAM Systems, Inc. (NYSE: EPAM)
XLABW vs EPAM Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, EPAM has a market cap of 6.3B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while EPAM trades at $122.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas EPAM's P/E ratio is 9.71. In terms of profitability, XLABW's ROE is N/A, compared to EPAM's ROE of +0.11%. Regarding short-term risk, XLABW is more volatile compared to EPAM. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check EPAM's competition here
Ingram Micro Holding Corporation (NYSE: INGM)
XLABW vs INGM Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, INGM has a market cap of 6.1B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while INGM trades at $26.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas INGM's P/E ratio is 8.78. In terms of profitability, XLABW's ROE is N/A, compared to INGM's ROE of +0.10%. Regarding short-term risk, XLABW is more volatile compared to INGM. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check INGM's competition here
ExlService Holdings, Inc. (NASDAQ: EXLS)
XLABW vs EXLS Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, EXLS has a market cap of 6B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while EXLS trades at $39.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas EXLS's P/E ratio is 19.27. In terms of profitability, XLABW's ROE is N/A, compared to EXLS's ROE of +0.28%. Regarding short-term risk, XLABW is more volatile compared to EXLS. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check EXLS's competition here
Science Applications International Corporation (NASDAQ: SAIC)
XLABW vs SAIC Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, SAIC has a market cap of 5.6B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while SAIC trades at $133.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas SAIC's P/E ratio is 11.95. In terms of profitability, XLABW's ROE is N/A, compared to SAIC's ROE of +0.26%. Regarding short-term risk, XLABW is more volatile compared to SAIC. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check SAIC's competition here
Applied Digital Corp. (NASDAQ: APLD)
XLABW vs APLD Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, APLD has a market cap of 5.5B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while APLD trades at $18.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas APLD's P/E ratio is -20.74. In terms of profitability, XLABW's ROE is N/A, compared to APLD's ROE of -0.28%. Regarding short-term risk, XLABW is more volatile compared to APLD. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check APLD's competition here
Maase Inc. (NASDAQ: MAAS)
XLABW vs MAAS Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, MAAS has a market cap of 5.3B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while MAAS trades at $12.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas MAAS's P/E ratio is -3.76. In terms of profitability, XLABW's ROE is N/A, compared to MAAS's ROE of -0.39%. Regarding short-term risk, XLABW is more volatile compared to MAAS. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check MAAS's competition here
Parsons Corporation (NYSE: PSN)
XLABW vs PSN Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, PSN has a market cap of 4.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while PSN trades at $44.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas PSN's P/E ratio is 18.88. In terms of profitability, XLABW's ROE is N/A, compared to PSN's ROE of +0.06%. Regarding short-term risk, XLABW is more volatile compared to PSN. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check PSN's competition here
Insight Enterprises, Inc. (NASDAQ: NSIT)
XLABW vs NSIT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, NSIT has a market cap of 4.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while NSIT trades at $160.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas NSIT's P/E ratio is 13.23. In terms of profitability, XLABW's ROE is N/A, compared to NSIT's ROE of +0.13%. Regarding short-term risk, XLABW is more volatile compared to NSIT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check NSIT's competition here
GDS Holdings Limited (NASDAQ: GDS)
XLABW vs GDS Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, GDS has a market cap of 4.5B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while GDS trades at $23.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas GDS's P/E ratio is 9.31. In terms of profitability, XLABW's ROE is N/A, compared to GDS's ROE of +0.13%. Regarding short-term risk, XLABW is more volatile compared to GDS. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check GDS's competition here
NCR Corporation (NYSE: NCR)
XLABW vs NCR Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, NCR has a market cap of 3.8B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while NCR trades at $27.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas NCR's P/E ratio is 49.24. In terms of profitability, XLABW's ROE is N/A, compared to NCR's ROE of +0.17%. Regarding short-term risk, XLABW is more volatile compared to NCR. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check NCR's competition here
Cipher Mining Inc. (NASDAQ: CIFR)
XLABW vs CIFR Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CIFR has a market cap of 3.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CIFR trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CIFR's P/E ratio is -3.14. In terms of profitability, XLABW's ROE is N/A, compared to CIFR's ROE of -1.56%. Regarding short-term risk, XLABW is more volatile compared to CIFR. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CIFR's competition here
WNS (Holdings) Limited (NYSE: WNS)
XLABW vs WNS Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, WNS has a market cap of 3.3B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while WNS trades at $76.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas WNS's P/E ratio is 21.36. In terms of profitability, XLABW's ROE is N/A, compared to WNS's ROE of +0.21%. Regarding short-term risk, XLABW is more volatile compared to WNS. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check WNS's competition here
Kyndryl Holdings, Inc. (NYSE: KD)
XLABW vs KD Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, KD has a market cap of 2.9B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while KD trades at $13.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas KD's P/E ratio is 13.77. In terms of profitability, XLABW's ROE is N/A, compared to KD's ROE of +0.29%. Regarding short-term risk, XLABW is more volatile compared to KD. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check KD's competition here
Csquare Inc. (NYSE: CSQR)
XLABW vs CSQR Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CSQR has a market cap of 2.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CSQR trades at $16.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CSQR's P/E ratio is -13.41. In terms of profitability, XLABW's ROE is N/A, compared to CSQR's ROE of N/A. Regarding short-term risk, XLABW is more volatile compared to CSQR. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CSQR's competition here
Perficient, Inc. (NASDAQ: PRFT)
XLABW vs PRFT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, PRFT has a market cap of 2.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while PRFT trades at $75.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas PRFT's P/E ratio is 36.34. In terms of profitability, XLABW's ROE is N/A, compared to PRFT's ROE of +0.21%. Regarding short-term risk, XLABW is more volatile compared to PRFT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check PRFT's competition here
DXC Technology Company (NYSE: DXC)
XLABW vs DXC Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, DXC has a market cap of 2.2B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while DXC trades at $13.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas DXC's P/E ratio is 4.19. In terms of profitability, XLABW's ROE is N/A, compared to DXC's ROE of +0.04%. Regarding short-term risk, XLABW is more volatile compared to DXC. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check DXC's competition here
Innodata Inc. (NASDAQ: INOD)
XLABW vs INOD Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, INOD has a market cap of 1.8B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while INOD trades at $52.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas INOD's P/E ratio is 40.02. In terms of profitability, XLABW's ROE is N/A, compared to INOD's ROE of +0.38%. Regarding short-term risk, XLABW is more volatile compared to INOD. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check INOD's competition here
Formula Systems (1985) Ltd. (NASDAQ: FORTY)
XLABW vs FORTY Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, FORTY has a market cap of 1.8B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while FORTY trades at $114.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas FORTY's P/E ratio is 24.33. In terms of profitability, XLABW's ROE is N/A, compared to FORTY's ROE of +0.54%. Regarding short-term risk, XLABW is more volatile compared to FORTY. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check FORTY's competition here
Globant S.A. (NYSE: GLOB)
XLABW vs GLOB Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, GLOB has a market cap of 1.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while GLOB trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas GLOB's P/E ratio is 6.49. In terms of profitability, XLABW's ROE is N/A, compared to GLOB's ROE of +0.05%. Regarding short-term risk, XLABW is more volatile compared to GLOB. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check GLOB's competition here
Concentrix Corporation (NASDAQ: CNXC)
XLABW vs CNXC Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CNXC has a market cap of 1.7B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CNXC trades at $27.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CNXC's P/E ratio is 2.54. In terms of profitability, XLABW's ROE is N/A, compared to CNXC's ROE of -0.96%. Regarding short-term risk, XLABW is more volatile compared to CNXC. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CNXC's competition here
Everforth, Inc. (NYSE: EFOR)
XLABW vs EFOR Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, EFOR has a market cap of 1.6B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while EFOR trades at $38.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas EFOR's P/E ratio is 8.89. In terms of profitability, XLABW's ROE is N/A, compared to EFOR's ROE of +0.05%. Regarding short-term risk, XLABW is more volatile compared to EFOR. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check EFOR's competition here
Mega Fortune Company Limited (NASDAQ: MGRT)
XLABW vs MGRT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, MGRT has a market cap of 1.5B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while MGRT trades at $107.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas MGRT's P/E ratio is 632.65. In terms of profitability, XLABW's ROE is N/A, compared to MGRT's ROE of -0.04%. Regarding short-term risk, XLABW is more volatile compared to MGRT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check MGRT's competition here
Thoughtworks Holding, Inc. (NASDAQ: TWKS)
XLABW vs TWKS Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, TWKS has a market cap of 1.4B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while TWKS trades at $4.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas TWKS's P/E ratio is -12.08. In terms of profitability, XLABW's ROE is N/A, compared to TWKS's ROE of -0.09%. Regarding short-term risk, XLABW is more volatile compared to TWKS. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check TWKS's competition here
Keel Infrastructure Corp. (NASDAQ: KEEL)
XLABW vs KEEL Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, KEEL has a market cap of 1.4B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while KEEL trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas KEEL's P/E ratio is N/A. In terms of profitability, XLABW's ROE is N/A, compared to KEEL's ROE of -0.90%. Regarding short-term risk, XLABW is more volatile compared to KEEL. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check KEEL's competition here
Bitfarms Ltd. (NASDAQ: BITF)
XLABW vs BITF Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, BITF has a market cap of 1.3B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while BITF trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas BITF's P/E ratio is -5.68. In terms of profitability, XLABW's ROE is N/A, compared to BITF's ROE of -0.90%. Regarding short-term risk, XLABW is more volatile compared to BITF. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check BITF's competition here
BIT Mining Limited (NYSE: BTCM)
XLABW vs BTCM Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, BTCM has a market cap of 1.3B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while BTCM trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas BTCM's P/E ratio is -0.53. In terms of profitability, XLABW's ROE is N/A, compared to BTCM's ROE of +0.29%. Regarding short-term risk, XLABW is more volatile compared to BTCM. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check BTCM's competition here
Clarivate Plc (NYSE: CLVT)
XLABW vs CLVT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CLVT has a market cap of 1.1B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CLVT trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CLVT's P/E ratio is 2.38. In terms of profitability, XLABW's ROE is N/A, compared to CLVT's ROE of -0.07%. Regarding short-term risk, XLABW is more volatile compared to CLVT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CLVT's competition here
VNET Group, Inc. (NASDAQ: VNET)
XLABW vs VNET Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, VNET has a market cap of 1.1B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while VNET trades at $3.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas VNET's P/E ratio is -3.29. In terms of profitability, XLABW's ROE is N/A, compared to VNET's ROE of -0.47%. Regarding short-term risk, XLABW is more volatile compared to VNET. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check VNET's competition here
NCR Voyix Corporation (NYSE: VYX)
XLABW vs VYX Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, VYX has a market cap of 1B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while VYX trades at $7.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas VYX's P/E ratio is 8.52. In terms of profitability, XLABW's ROE is N/A, compared to VYX's ROE of +0.07%. Regarding short-term risk, XLABW is more volatile compared to VYX. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check VYX's competition here
BigBear.ai Holdings, Inc. (NYSE: BBAI)
XLABW vs BBAI Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, BBAI has a market cap of 1B. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while BBAI trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas BBAI's P/E ratio is -3.14. In terms of profitability, XLABW's ROE is N/A, compared to BBAI's ROE of -0.12%. Regarding short-term risk, XLABW is more volatile compared to BBAI. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check BBAI's competition here
SharonAI Holdings, Inc. Class A Common Stock (NASDAQ: SHAZ)
XLABW vs SHAZ Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, SHAZ has a market cap of 948.4M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while SHAZ trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas SHAZ's P/E ratio is -0.87. In terms of profitability, XLABW's ROE is N/A, compared to SHAZ's ROE of -1.57%. Regarding short-term risk, XLABW is more volatile compared to SHAZ. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check SHAZ's competition here
BigBear.ai Holdings, Inc. WT (NYSE: BBAI-WT)
XLABW vs BBAI-WT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, BBAI-WT has a market cap of 942.5M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while BBAI-WT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas BBAI-WT's P/E ratio is -0.03. In terms of profitability, XLABW's ROE is N/A, compared to BBAI-WT's ROE of -0.12%. Regarding short-term risk, XLABW is more volatile compared to BBAI-WT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check BBAI-WT's competition here
ASGN Incorporated (NYSE: ASGN)
XLABW vs ASGN Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, ASGN has a market cap of 895M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while ASGN trades at $20.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas ASGN's P/E ratio is 9.32. In terms of profitability, XLABW's ROE is N/A, compared to ASGN's ROE of +0.05%. Regarding short-term risk, XLABW is more volatile compared to ASGN. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check ASGN's competition here
SOLAI Limited (NYSE: SLAI)
XLABW vs SLAI Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, SLAI has a market cap of 880.1M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while SLAI trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas SLAI's P/E ratio is -1.40. In terms of profitability, XLABW's ROE is N/A, compared to SLAI's ROE of -0.83%. Regarding short-term risk, XLABW is more volatile compared to SLAI. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check SLAI's competition here
Magic Software Enterprises Ltd. (NASDAQ: MGIC)
XLABW vs MGIC Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, MGIC has a market cap of 853.3M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while MGIC trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas MGIC's P/E ratio is 21.20. In terms of profitability, XLABW's ROE is N/A, compared to MGIC's ROE of +0.07%. Regarding short-term risk, XLABW is more volatile compared to MGIC. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check MGIC's competition here
N-able, Inc. (NYSE: NABL)
XLABW vs NABL Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, NABL has a market cap of 847.2M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while NABL trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas NABL's P/E ratio is 11.50. In terms of profitability, XLABW's ROE is N/A, compared to NABL's ROE of -0.01%. Regarding short-term risk, XLABW is more volatile compared to NABL. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check NABL's competition here
Cantaloupe, Inc. (NASDAQ: CTLP)
XLABW vs CTLP Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CTLP has a market cap of 825.8M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CTLP trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CTLP's P/E ratio is 280.00. In terms of profitability, XLABW's ROE is N/A, compared to CTLP's ROE of +0.01%. Regarding short-term risk, XLABW is more volatile compared to CTLP. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CTLP's competition here
Clarivate Plc (NYSE: CLVT-PA)
XLABW vs CLVT-PA Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CLVT-PA has a market cap of 755.5M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CLVT-PA trades at $4.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CLVT-PA's P/E ratio is -7.93. In terms of profitability, XLABW's ROE is N/A, compared to CLVT-PA's ROE of -0.07%. Regarding short-term risk, XLABW is more volatile compared to CLVT-PA. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CLVT-PA's competition here
TaskUs, Inc. (NASDAQ: TASK)
XLABW vs TASK Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, TASK has a market cap of 753.7M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while TASK trades at $8.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas TASK's P/E ratio is 5.48. In terms of profitability, XLABW's ROE is N/A, compared to TASK's ROE of +0.25%. Regarding short-term risk, XLABW is more volatile compared to TASK. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check TASK's competition here
Grid Dynamics Holdings, Inc. (NASDAQ: GDYN)
XLABW vs GDYN Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, GDYN has a market cap of 632.4M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while GDYN trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas GDYN's P/E ratio is 20.51. In terms of profitability, XLABW's ROE is N/A, compared to GDYN's ROE of +0.01%. Regarding short-term risk, XLABW is more volatile compared to GDYN. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check GDYN's competition here
Performant Healthcare, Inc. (NASDAQ: PHLT)
XLABW vs PHLT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, PHLT has a market cap of 611.6M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while PHLT trades at $7.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas PHLT's P/E ratio is -775.00. In terms of profitability, XLABW's ROE is N/A, compared to PHLT's ROE of -0.13%. Regarding short-term risk, XLABW is more volatile compared to PHLT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check PHLT's competition here
IBEX Limited (NASDAQ: IBEX)
XLABW vs IBEX Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, IBEX has a market cap of 606.1M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while IBEX trades at $45.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas IBEX's P/E ratio is 12.86. In terms of profitability, XLABW's ROE is N/A, compared to IBEX's ROE of +0.29%. Regarding short-term risk, XLABW is more volatile compared to IBEX. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check IBEX's competition here
HIVE Digital Technologies Ltd. (NASDAQ: HIVE)
XLABW vs HIVE Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, HIVE has a market cap of 556.8M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while HIVE trades at $2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas HIVE's P/E ratio is -1.66. In terms of profitability, XLABW's ROE is N/A, compared to HIVE's ROE of -0.60%. Regarding short-term risk, XLABW is more volatile compared to HIVE. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check HIVE's competition here
WhiteFiber, Inc. Ordinary Shares (NASDAQ: WYFI)
XLABW vs WYFI Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, WYFI has a market cap of 456.9M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while WYFI trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas WYFI's P/E ratio is -6.99. In terms of profitability, XLABW's ROE is N/A, compared to WYFI's ROE of -0.09%. Regarding short-term risk, XLABW is more volatile compared to WYFI. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check WYFI's competition here
Verra Mobility Corporation (NASDAQ: VRRM)
XLABW vs VRRM Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, VRRM has a market cap of 434.7M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while VRRM trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas VRRM's P/E ratio is 2.20. In terms of profitability, XLABW's ROE is N/A, compared to VRRM's ROE of +0.15%. Regarding short-term risk, XLABW is more volatile compared to VRRM. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check VRRM's competition here
Telos Corporation (NASDAQ: TLS)
XLABW vs TLS Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, TLS has a market cap of 299.7M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while TLS trades at $4.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas TLS's P/E ratio is 22.28. In terms of profitability, XLABW's ROE is N/A, compared to TLS's ROE of -0.16%. Regarding short-term risk, XLABW is more volatile compared to TLS. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check TLS's competition here
The Hackett Group, Inc. (NASDAQ: HCKT)
XLABW vs HCKT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, HCKT has a market cap of 281.1M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while HCKT trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas HCKT's P/E ratio is 7.79. In terms of profitability, XLABW's ROE is N/A, compared to HCKT's ROE of +0.22%. Regarding short-term risk, XLABW is more volatile compared to HCKT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check HCKT's competition here
Webull Corporation Incentive Warrant (NASDAQ: BULLZ)
XLABW vs BULLZ Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, BULLZ has a market cap of 260.4M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while BULLZ trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas BULLZ's P/E ratio is N/A. In terms of profitability, XLABW's ROE is N/A, compared to BULLZ's ROE of +0.04%. Regarding short-term risk, XLABW is less volatile compared to BULLZ. This indicates lower risk in terms of short-term price fluctuations for XLABW.Check BULLZ's competition here
Alight, Inc. (NYSE: ALIT)
XLABW vs ALIT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, ALIT has a market cap of 237.8M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while ALIT trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas ALIT's P/E ratio is 3.73. In terms of profitability, XLABW's ROE is N/A, compared to ALIT's ROE of -1.59%. Regarding short-term risk, XLABW is more volatile compared to ALIT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check ALIT's competition here
Conduent Incorporated (NASDAQ: CNDT)
XLABW vs CNDT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CNDT has a market cap of 216.2M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CNDT trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CNDT's P/E ratio is -3.66. In terms of profitability, XLABW's ROE is N/A, compared to CNDT's ROE of -0.30%. Regarding short-term risk, XLABW is more volatile compared to CNDT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CNDT's competition here
TSS, Inc. (NASDAQ: TSSI)
XLABW vs TSSI Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, TSSI has a market cap of 199.5M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while TSSI trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas TSSI's P/E ratio is 14.43. In terms of profitability, XLABW's ROE is N/A, compared to TSSI's ROE of +0.19%. Regarding short-term risk, XLABW is more volatile compared to TSSI. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check TSSI's competition here
Startek, Inc. (NYSE: SRT)
XLABW vs SRT Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, SRT has a market cap of 178.3M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while SRT trades at $4.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas SRT's P/E ratio is -6.60. In terms of profitability, XLABW's ROE is N/A, compared to SRT's ROE of -0.00%. Regarding short-term risk, XLABW is more volatile compared to SRT. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check SRT's competition here
Robot Consulting Co., Ltd. ADS (NASDAQ: LAWR)
XLABW vs LAWR Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, LAWR has a market cap of 172.4M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while LAWR trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas LAWR's P/E ratio is -46.87. In terms of profitability, XLABW's ROE is N/A, compared to LAWR's ROE of +1.39%. Regarding short-term risk, XLABW is more volatile compared to LAWR. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check LAWR's competition here
Computer Task Group, Incorporated (NASDAQ: CTG)
XLABW vs CTG Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CTG has a market cap of 169M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CTG trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CTG's P/E ratio is 350.00. In terms of profitability, XLABW's ROE is N/A, compared to CTG's ROE of +0.07%. Regarding short-term risk, XLABW is more volatile compared to CTG. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CTG's competition here
KORE Group Holdings, Inc. (NYSE: KORE)
XLABW vs KORE Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, KORE has a market cap of 163M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while KORE trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas KORE's P/E ratio is -2.86. In terms of profitability, XLABW's ROE is N/A, compared to KORE's ROE of +0.48%. Regarding short-term risk, XLABW is more volatile compared to KORE. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check KORE's competition here
Unisys Corporation (NYSE: UIS)
XLABW vs UIS Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, UIS has a market cap of 161.1M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while UIS trades at $2.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas UIS's P/E ratio is 2.66. In terms of profitability, XLABW's ROE is N/A, compared to UIS's ROE of +1.35%. Regarding short-term risk, XLABW is more volatile compared to UIS. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check UIS's competition here
Endava plc (NYSE: DAVA)
XLABW vs DAVA Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, DAVA has a market cap of 114.9M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while DAVA trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas DAVA's P/E ratio is -0.19. In terms of profitability, XLABW's ROE is N/A, compared to DAVA's ROE of -0.88%. Regarding short-term risk, XLABW is more volatile compared to DAVA. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check DAVA's competition here
Alithya Group Inc. (NASDAQ: ALYA)
XLABW vs ALYA Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, ALYA has a market cap of 110.3M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while ALYA trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas ALYA's P/E ratio is -3.42. In terms of profitability, XLABW's ROE is N/A, compared to ALYA's ROE of -0.09%. Regarding short-term risk, XLABW is more volatile compared to ALYA. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check ALYA's competition here
Yuanbao Inc. American Depositary Shares (NASDAQ: YB)
XLABW vs YB Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, YB has a market cap of 90.9M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while YB trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas YB's P/E ratio is 2.45. In terms of profitability, XLABW's ROE is N/A, compared to YB's ROE of +0.43%. Regarding short-term risk, XLABW is more volatile compared to YB. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check YB's competition here
CSP Inc. (NASDAQ: CSPI)
XLABW vs CSPI Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CSPI has a market cap of 78.1M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CSPI trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CSPI's P/E ratio is -110.71. In terms of profitability, XLABW's ROE is N/A, compared to CSPI's ROE of -0.02%. Regarding short-term risk, XLABW is more volatile compared to CSPI. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CSPI's competition here
TTEC Holdings, Inc. (NASDAQ: TTEC)
XLABW vs TTEC Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, TTEC has a market cap of 76.2M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while TTEC trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas TTEC's P/E ratio is 1.61. In terms of profitability, XLABW's ROE is N/A, compared to TTEC's ROE of -1.62%. Regarding short-term risk, XLABW is more volatile compared to TTEC. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check TTEC's competition here
ZenaTech, Inc. (NASDAQ: ZENA)
XLABW vs ZENA Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, ZENA has a market cap of 63.7M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while ZENA trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas ZENA's P/E ratio is -0.64. In terms of profitability, XLABW's ROE is N/A, compared to ZENA's ROE of -1.18%. Regarding short-term risk, XLABW is more volatile compared to ZENA. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check ZENA's competition here
WidePoint Corporation (AMEX: WYY)
XLABW vs WYY Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, WYY has a market cap of 61.9M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while WYY trades at $6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas WYY's P/E ratio is -47.62. In terms of profitability, XLABW's ROE is N/A, compared to WYY's ROE of -0.11%. Regarding short-term risk, XLABW is more volatile compared to WYY. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check WYY's competition here
Quantum X Labs Inc. (NASDAQ: QXL)
XLABW vs QXL Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, QXL has a market cap of 58.8M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while QXL trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas QXL's P/E ratio is 7.11. In terms of profitability, XLABW's ROE is N/A, compared to QXL's ROE of -0.14%. Regarding short-term risk, XLABW is more volatile compared to QXL. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check QXL's competition here
Castellum, Inc. (AMEX: CTM)
XLABW vs CTM Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CTM has a market cap of 54.7M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CTM trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CTM's P/E ratio is -44.19. In terms of profitability, XLABW's ROE is N/A, compared to CTM's ROE of -0.06%. Regarding short-term risk, XLABW is more volatile compared to CTM. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CTM's competition here
ChronoScale Corporation (NASDAQ: CHRN)
XLABW vs CHRN Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CHRN has a market cap of 53.7M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CHRN trades at $15.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CHRN's P/E ratio is -2.65. In terms of profitability, XLABW's ROE is N/A, compared to CHRN's ROE of N/A. Regarding short-term risk, XLABW is more volatile compared to CHRN. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CHRN's competition here
SAIHEAT Limited (NASDAQ: SAIH)
XLABW vs SAIH Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, SAIH has a market cap of 50.6M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while SAIH trades at $27.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas SAIH's P/E ratio is -7.83. In terms of profitability, XLABW's ROE is N/A, compared to SAIH's ROE of -0.68%. Regarding short-term risk, XLABW is more volatile compared to SAIH. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check SAIH's competition here
Sify Technologies Limited Rights expiring 6/21/2024 (NASDAQ: SIFYR)
XLABW vs SIFYR Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, SIFYR has a market cap of 44.3M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while SIFYR trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas SIFYR's P/E ratio is N/A. In terms of profitability, XLABW's ROE is N/A, compared to SIFYR's ROE of N/A. Regarding short-term risk, XLABW is more volatile compared to SIFYR. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check SIFYR's competition here
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO)
XLABW vs EKSO Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, EKSO has a market cap of 38.6M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while EKSO trades at $15.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas EKSO's P/E ratio is -3.11. In terms of profitability, XLABW's ROE is N/A, compared to EKSO's ROE of -1.27%. Regarding short-term risk, XLABW is more volatile compared to EKSO. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check EKSO's competition here
9F Inc. (NASDAQ: JFU)
XLABW vs JFU Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, JFU has a market cap of 33M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while JFU trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas JFU's P/E ratio is 1.42. In terms of profitability, XLABW's ROE is N/A, compared to JFU's ROE of +0.02%. Regarding short-term risk, XLABW is more volatile compared to JFU. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check JFU's competition here
CLPS Incorporation (NASDAQ: CLPS)
XLABW vs CLPS Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CLPS has a market cap of 27.5M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CLPS trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CLPS's P/E ratio is -3.88. In terms of profitability, XLABW's ROE is N/A, compared to CLPS's ROE of -0.12%. Regarding short-term risk, XLABW is more volatile compared to CLPS. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CLPS's competition here
ChowChow Cloud International Holdings Ltd. (AMEX: CHOW)
XLABW vs CHOW Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CHOW has a market cap of 18.8M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CHOW trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CHOW's P/E ratio is -5.90. In terms of profitability, XLABW's ROE is N/A, compared to CHOW's ROE of -0.58%. Regarding short-term risk, XLABW is more volatile compared to CHOW. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CHOW's competition here
DarkHorse Technologies Inc. (NASDAQ: DRK)
XLABW vs DRK Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, DRK has a market cap of 17.7M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while DRK trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas DRK's P/E ratio is -0.24. In terms of profitability, XLABW's ROE is N/A, compared to DRK's ROE of N/A. Regarding short-term risk, XLABW is more volatile compared to DRK. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check DRK's competition here
Veea Inc. (NASDAQ: VEEA)
XLABW vs VEEA Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, VEEA has a market cap of 13.1M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while VEEA trades at $4.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas VEEA's P/E ratio is -0.84. In terms of profitability, XLABW's ROE is N/A, compared to VEEA's ROE of +51.66%. Regarding short-term risk, XLABW is more volatile compared to VEEA. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check VEEA's competition here
Sigma Labs, Inc. (NASDAQ: SGLB)
XLABW vs SGLB Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, SGLB has a market cap of 11.3M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while SGLB trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas SGLB's P/E ratio is -1.37. In terms of profitability, XLABW's ROE is N/A, compared to SGLB's ROE of -2.61%. Regarding short-term risk, XLABW is more volatile compared to SGLB. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check SGLB's competition here
Alarum Technologies Ltd. (NASDAQ: ALAR)
XLABW vs ALAR Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, ALAR has a market cap of 10.8M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while ALAR trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas ALAR's P/E ratio is 2.23. In terms of profitability, XLABW's ROE is N/A, compared to ALAR's ROE of +0.04%. Regarding short-term risk, XLABW is more volatile compared to ALAR. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check ALAR's competition here
Global Engine Group Holding Limited Ordinary Shares (NASDAQ: GLE)
XLABW vs GLE Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, GLE has a market cap of 9.4M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while GLE trades at $4.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas GLE's P/E ratio is -6.28. In terms of profitability, XLABW's ROE is N/A, compared to GLE's ROE of +0.20%. Regarding short-term risk, XLABW is more volatile compared to GLE. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check GLE's competition here
Cycurion, Inc. Common Stock (NASDAQ: CYCU)
XLABW vs CYCU Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, CYCU has a market cap of 7.2M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while CYCU trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas CYCU's P/E ratio is -0.25. In terms of profitability, XLABW's ROE is N/A, compared to CYCU's ROE of -0.71%. Regarding short-term risk, XLABW is more volatile compared to CYCU. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check CYCU's competition here
Data Storage Corporation (NASDAQ: DTST)
XLABW vs DTST Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, DTST has a market cap of 7.1M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while DTST trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas DTST's P/E ratio is 43.43. In terms of profitability, XLABW's ROE is N/A, compared to DTST's ROE of +0.71%. Regarding short-term risk, XLABW is more volatile compared to DTST. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check DTST's competition here
ARB IOT Group Limited (NASDAQ: ARBB)
XLABW vs ARBB Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, ARBB has a market cap of 7M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while ARBB trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas ARBB's P/E ratio is -0.52. In terms of profitability, XLABW's ROE is N/A, compared to ARBB's ROE of -0.07%. Regarding short-term risk, XLABW is more volatile compared to ARBB. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check ARBB's competition here
LZ Technology Holdings Limited Class B Ordinary Shares (NASDAQ: LZMH)
XLABW vs LZMH Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, LZMH has a market cap of 6.8M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while LZMH trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas LZMH's P/E ratio is -0.27. In terms of profitability, XLABW's ROE is N/A, compared to LZMH's ROE of -3.05%. Regarding short-term risk, XLABW is more volatile compared to LZMH. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check LZMH's competition here
Veea Inc. (NASDAQ: VEEAW)
XLABW vs VEEAW Comparison October 2026
Exascale Labs Holdings Inc. Warrant (NASDAQ: XLABW) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, XLABW stands at 5.7M. In comparison, VEEAW has a market cap of 5.6M. Regarding current trading prices, XLABW is priced at $0.20 on the NASDAQ, while VEEAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
XLABW currently has a P/E ratio of 0.98, whereas VEEAW's P/E ratio is N/A. In terms of profitability, XLABW's ROE is N/A, compared to VEEAW's ROE of +51.66%. Regarding short-term risk, XLABW is more volatile compared to VEEAW. This indicates higher risk in terms of short-term price fluctuations for XLABW.Check VEEAW's competition here